Related Experiment Video

Updated: Jul 18, 2026

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
09:31

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

[Cerebral amyloid angiopathy, recurrent intracerebral haemorrhages and Down's syndrome]

J Romero López1, E Rivas Infante, J L Maciñeiras Montero

  • 1Sección de Neurología, Hospital do Meixoeiro, Vigo. jesús.romero.lópez@sergas.es

Neurologia (Barcelona, Spain)
|November 16, 2006
PubMed

Insights

Middle-age individuals with Down's syndrome can develop Alzheimer's-like dementia. Autopsy confirmed cerebral amyloid angiopathy (CAA) and Alzheimer's pathology in a patient with recurrent hemorrhages.

Area of Science:

  • Neuropathology
  • Genetics
  • Geriatrics

Background:

  • Down's syndrome is associated with an increased risk of Alzheimer's disease.
  • Cerebral amyloid angiopathy (CAA) is a common finding in Alzheimer's disease and can cause recurrent intracerebral hemorrhage.
  • The relationship between Down's syndrome, CAA, and Alzheimer's disease requires further investigation.

Observation:

  • The study presents a case of a middle-aged male with Down's syndrome experiencing recurrent lobar intracerebral hemorrhage.
  • Autopsy revealed characteristic lesions of CAA in cerebral arteries.
  • Alzheimer's disease pathology, primarily in the entorhinal cortex and hippocampus, was also identified.

Findings:

  • The case demonstrates a co-occurrence of cerebral amyloid angiopathy and Alzheimer's disease pathology in a patient with Down's syndrome.
  • This finding supports a potential link between these conditions.
  • The study highlights the need for anatomical-pathological confirmation for definitive CAA diagnosis.

Implications:

  • Understanding the interplay between Down's syndrome, beta-amyloid protein, apolipoprotein alleles, CAA, and Alzheimer's disease is crucial.
  • This research may inform diagnostic and therapeutic strategies for dementia in Down's syndrome.
  • Further studies are warranted to elucidate the precise pathological mechanisms involved.

More Related Videos

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats06:39

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats

Published on: October 17, 2018

Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases07:47

Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases

Published on: December 6, 2016

Related Concept Videos

Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...